2022
898-P: Impact of Switching to a High-Deductible Health Plan on Patients’ Out-of-Pocket Expenditures for Glucose-Lowering Drugs
JIANG D, HERRIN J, VAN HOUTEN H, MCCOY R. 898-P: Impact of Switching to a High-Deductible Health Plan on Patients’ Out-of-Pocket Expenditures for Glucose-Lowering Drugs. Diabetes 2022, 71 DOI: 10.2337/db22-898-p.Peer-Reviewed Original ResearchHigh-deductible health plansGlucose-lowering drugsHDHP enrolleesOOP expensesHealth outcomesPocket expenditureHealth plansBurden of treatmentCostly health conditionsPoor health outcomesDeductible Health PlansGlycemic managementHigh-value careKidney diseaseDiabetes managementOOP costsValue careOOP expenditurePrescription drugsDiabetesHealth conditionsDirect costsDrugsEnrolleesHealth insurance
2011
Effectiveness and Cost of a Transitional Care Program for Heart Failure: A Prospective Study With Concurrent Controls
Stauffer BD, Fullerton C, Fleming N, Ogola G, Herrin J, Stafford PM, Ballard DJ. Effectiveness and Cost of a Transitional Care Program for Heart Failure: A Prospective Study With Concurrent Controls. JAMA Internal Medicine 2011, 171: 1238-1243. PMID: 21788541, DOI: 10.1001/archinternmed.2011.274.Peer-Reviewed Original ResearchConceptsTransitional care programNurse-led transitional care programHeart failureLength of stayReadmission ratesCare programHealth care systemProspective studyCare systemCause readmission rateDirect costsConcurrent controlsBaylor Health Care SystemBudget impact analysisPostintervention periodMedicare patientsPatientsReal-world settingInterventionReimbursement experienceStaySecular reductionCurrent payment systemHospitalPayment reform